Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms Nanophase Technologies Corporation).
Reporting Period: Quarterly Report (Form 10-Q) for the period ended September 30, 1998.
Business Overview: The Company develops and sells nanocrystalline materials. It transitioned from a development stage to commercial production in early 1997. Revenue is derived from product shipments, development arrangements, and licensing.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 1998 | Nine Months Ended Sep 30, 1998 |
|---|---|---|
| Total Revenue | $180,568 | $1,102,280 |
| Net Loss | $(1,420,851) | $(3,907,665) |
| Net Loss Per Share | $(0.11) | $(0.32) |
| Cash and Cash Equivalents | $1,098,278 (Sep 30, 1998) | N/A |
| Total Investments | $26,504,632 (Sep 30, 1998) | N/A |
| Accumulated Deficit | $(17,652,336) | N/A |
| Operating Cash Flow | N/A | $(2,912,111) Used |
Liquidity: As of September 30, 1998, the Company held approximately $27.6 million in cash, cash equivalents, and investments. Current liabilities totaled $1,199,160.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased significantly compared to the prior year. For the three months ended September 30, 1998, revenue dropped from $1,212,948 to $180,568. For the nine months, it fell from $2,245,415 to $1,102,280. This was driven primarily by a reduction in "Other revenue" (development and licensing), which dropped to zero for the quarter and $143,484 for the nine months.
- Expense Increases: Despite lower revenue, operating expenses increased. Research and development (R&D) expenses rose to $344,657 (quarter) and $1,135,679 (nine months) due to external development arrangements. Selling, general, and administrative (SG&A) expenses increased to $969,761 (quarter) and $2,562,424 (nine months), attributed to costs of being a public company and expanded sales efforts.
- Cost of Revenue: Cost of revenue decreased to $668,616 (quarter) and $2,325,323 (nine months) due to reduced shipments, though the cost of revenue as a percentage of total revenue increased due to fixed costs.
- Interest Income: Interest income surged to $381,615 (quarter) and $1,169,481 (nine months) compared to $25,645 and $57,392 in 1997, resulting from the investment of IPO proceeds.
Outlook, Risks, and Contingencies
- Legal Proceedings: The Company is a defendant in a consolidated securities class action lawsuit filed on October 30, 1998, alleging material misstatements in its IPO registration. The complaint seeks unquantified damages and rescission. The Company intends to defend vigorously but cannot predict the outcome or potential material adverse effects.
- Liquidity Outlook: Management believes current cash and IPO proceeds are adequate to fund operations for the foreseeable future. However, future capital requirements depend on customer acceptance and R&D progress. Additional financing may be required, which could be dilutive.
- Year 2000 Compliance: The Company is assessing IT, manufacturing, and third-party systems for Year 2000 compliance. While it believes costs will not be material, a worst-case scenario involving supplier or customer failures could materially disrupt operations.
- Tax Position: The Company has a net operating loss carryforward of approximately $16.9 million and a foreign tax credit carryforward of $156,000. Utilization of these may be limited by ownership change rules.
- Stockholder Rights Plan: On October 27, 1998, the Company adopted a stockholder rights plan, distributing one right per share of common stock.
Investor Verification Checklist
- Revenue Sustainability: Verify the reasons for the sharp decline in "Other revenue" (development/licensing) and the ability to replace it with product sales.
- Legal Exposure: Monitor the status of the consolidated securities class action lawsuit and potential indemnification obligations to underwriters.
- Cash Burn Rate: Assess the rate of cash consumption from operations ($2.9 million used in nine months) against the $27.6 million cash/investment balance to determine runway.
- Year 2000 Risks: Confirm the status of third-party supplier and customer Year 2000 compliance, as the Company relies on them for raw materials and sales.
- R&D Efficiency: Evaluate the return on increased R&D spending ($1.1 million for nine months) given the concurrent revenue decline.